NASDAQ Welcomes Tandem Diabetes Care (NASDAQ: TNDM) to The

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
NASDAQ Welcomes Tandem Diabetes Care (NASDAQ: TNDM) to The NASDAQ Stock Market

NEW YORK, Nov. 14, 2013 (GLOBE NEWSWIRE) -- The NASDAQ OMX Group, Inc. (Nasdaq: NDAQ ) announced today that trading of Tandem Diabetes Care, Inc. (Nasdaq: TNDM ), a leading provider of insulin pump therapy, commenced on The NASDAQ Stock Market on November 14, 2013.

Tandem Diabetes Care, Inc. is dedicated to advancing the management of diabetes through novel technologies. The company offers a comprehensive, user-centric and integrated approach to product design, development, and customer care. Tandem Diabetes Care is based in San Diego, California.

"Tandem Diabetes Care is committed to the development of groundbreaking products for patients with diabetes," said Nelson Griggs, Senior Vice President, NASDAQ OMX. "We are proud to welcome Tandem to The NASDAQ Stock Market and congratulate them on a successful listing."

NASDAQ has consistently been the exchange of choice for innovative, industry-leading companies such as Tandem Diabetes Care. Tandem Diabetes Care joins the ranks of recently-listed San Diego based life sciences companies including Conatus Pharmaceuticals, Receptos, Ambit Biosciences, Sophiris Bio, Evoke Pharma, and Fate Therapeutics.

About NASDAQ OMX Group :

The inventor of the electronic exchange, The NASDAQ OMX Group, Inc., fuels economies and provides transformative technologies for the entire lifecycle of a trade - from risk management to trade to surveillance to clearing. In the U.S. and Europe, we own and operate 26 markets, 3 clearinghouses and 5 central securities depositories supporting equities, options, fixed income, derivatives, commodities, futures and structured products. Able to process more than 1 million messages per second at sub-40 microsecond speeds with 99.99% uptime, our technology drives more than 70 marketplaces in 50 developed and emerging countries into the future, powering 1 in 10 of the world's securities transactions. Our award-winning data products and worldwide indexes are the benchmarks in the financial industry. Home to approximately 3,400 listed companies worth $6 trillion in market cap whose innovations shape our world, we give the ideas of tomorrow access to capital today. Welcome to where the world takes a big leap forward, daily. Welcome to the NASDAQ OMX Century. To learn more, visit nasdaqomx.com . Follow us on Facebook ( http://www.facebook.com/NASDAQ ) and Twitter ( http://www.twitter.com/nasdaqomx ). (Symbol: NDAQ and member of S&P 500)

The information contained above is provided for informational and educational purposes only, and nothing contained herein should be construed as investment advice, either on behalf of a particular security or an overall investment strategy. Neither The NASDAQ OMX Group, Inc. nor any of its affiliates makes any recommendation to buy or sell any security or any representation about the financial condition of any company. Statements regarding NASDAQ-listed companies are not guarantees of future performance. Actual results may differ materially from those expressed or implied. Past performance is not indicative of future results. Investors should undertake their own due diligence and carefully evaluate companies before investing. ADVICE FROM A SECURITIES PROFESSIONAL IS STRONGLY ADVISED.

-NDAQG-

NASDAQ OMX Media Contact: Christine Barna (646) 441-5310

Scroll down for more posts ▼

Top 10 Most Recent News Articles

UEG's New Advisory Board: Elevating Patient Voices

Updated Category News Views 8

Breaking Ground with Patient Representation Today's not-so-sunny forecast from Barcelona wasn't about the weather. United European Gastroenterology (UEG) rolled out its shiny new Patient Representatives Advisory Board (PRAB) during UEG Week 2026. This isn't just another committee on a never-ending list—it's a serious platform aimed at turning patient murmurs into a...

Continue Reading
Antheia Secures $80M for Critical Medicine Onshoring

Updated Category News Views 10

Antheia's Bold Move to Onshore Medicine Production Folks, when it comes to pharmaceuticals, it's about time someone started serious about keeping things closer to home. Antheia just landed a huge $80 million conditional commitment from the U.S. Department of War's Office of Strategic Capital. The fine print? This isn't just about building business—it's a play to secure...

Continue Reading
Faith and Resilience in China: The Legacy of the Long March

Updated Category News Views 5

History's got chapters that stick with you, and the Long March is one of those stories that shake you to your core. It all started one October evening in 1934, when more than 86,000 soldiers from the Red Army found themselves on the banks of the Yudu River. It was a scene straight out of a novel: 800-odd boats held together with coffin boards and timber beams, all set to...

Continue Reading
Tomorrowland's Shanghai Return: An Electri-Lifesaver

Updated Category News Views 5

You know, every now and then, it's worth stepping out of the stock frenzy and diving into something as electrifying and far from the trading floor as Tomorrowland's latest Shanghai rendezvous. This ain't just any festival; it's the kind of hype that packs a punch—and frankly, it's a wild ride seeing such a spectacle set up shop in China, and sell out to boot. Partnering...

Continue Reading
AEVEX Faces 48-Hour Deadline for Investor Class Action

Updated Category News Views 4

Clock Ticking on AEVEX Lawsuit Participation Ah, the twists and turns of the stock market! AEVEX Corp. (NYSE: AVEX) finds itself knee-deep in a class action lawsuit, and investors have a mere 48 hours left to make their stand as the lead plaintiff. This legal saga stems from the company's April 2026 IPO and spills into the muddy waters of securities law violations....

Continue Reading
Lundbeck's Board Leadership Transitions into New Era

Updated Category News Views 4

A Fresh Chapter for Lundbeck's Board Leadership Lundbeck is sparking some fresh boardroom energy, and it's not just business as usual. Dorothea Wenzel, who's been steering the ship, is stepping down come 2027—AGM in sight. Now, in swings Lars Fruergaard Jørgensen, ready to grab the wheel. Yeah, we've got some seasoned pharma muscles flexing here. The Before and After:...

Continue Reading
ASTS Faces a Legal Countdown – Investors Take Note

Updated Category News Views 5

AST SpaceMobile's Legal Tangle AST SpaceMobile, Inc. (NASDAQ:ASTS) finds itself neck-deep in legal quagmire, with a class action lawsuit looming large. Investors who snapped up ASTS securities between March 4, 2025, and July 15, 2026, have until November 13, 2026, to reckon their grievances before the courts. This is no joke, folks. If you've lost dough because of shaky...

Continue Reading

Top 5 Most Recently Viewed Articles

Exploring the Rise and Fall of MedMen's Cannabis Empire

Updated Category News Views 178

Let's slice through the smoke and mirrors of MedMen's saga—a story that captures the dizzying heights and staggering lows of what was once the poster child for America's cannabis gold rush. The buzz is about a documentary from Bungalow Media + Entertainment that’s gearing up to pull back the curtain on Adam Bierman and his rollercoaster ride with MedMen. They kicked...

Continue Reading
Draganfly Secures $25 Million for Innovative Drone Solutions

Updated Category News Views 136

Overview of Recent Financial Activities Draganfly Inc. (NASDAQ: DPRO), a leader in drone technology and robotics, has made significant strides in its financial landscape by securing a registered direct offering. This initiative is designed to enhance their operational capabilities and support new product developments. Details of the Direct Offering In a recent...

Continue Reading
Current Sentiment Analysis: Canaan Inc's Short Interest Insights

Updated Category News Views 304

Canaan Inc's Current Short Interest Overview Canaan Inc (NYSE: CAN) is witnessing changes in its stock sentiment, particularly regarding its short interest. Recent reports indicate that the short interest, expressed as a percentage of the float, has dropped by 8.14%. Currently, 36.17 million shares are sold short, representing 8.58% of the total shares available for...

Continue Reading
iHerb's Chief Operating Officer Miriee Chang Set to Retire

Updated Category News Views 196

iHerb Announces Retirement of COO Miriee Chang iHerb, a global leader in online retail for wellness products, has announced the planned retirement of Chief Operating Officer Miriee Chang. This change marks a significant transition for the company, dedicated to maintaining its operational excellence and customer service quality. Continuity During the Transition Miriee...

Continue Reading
Liberty Broadband to Reveal Q4 2024 Performance in Upcoming Call

Updated Category News Views 103

Liberty Broadband Corporation's Upcoming Conference Call Liberty Broadband Corporation (Nasdaq: LBRDA, LBRDK, LBRDP) is gearing up for a significant event as it prepares to hold a conference call to unveil its financial results for the fourth quarter of 2024. This highly anticipated call is set to take place soon, providing an opportunity for stakeholders and interested...

Continue Reading